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Abstract
Glucose is a ubiquitous energy source for most living organisms. Its uptake activity closely 
reflects cellular metabolic demand in various physiopathological conditions. Extensive efforts 
such as positron emission tomography, magnetic resonance imaging and fluorescence microscopy 
have been made to specifically image glucose uptake but all with limitations. Here, we report a 
new platform to visualize glucose uptake activity in live cells and tissues by performing stimulated 
Raman scattering on a novel glucose analogue labeled with a small alkyne moiety. Cancer cells 
with differing metabolic activities can be distinguished. Heterogeneous uptake patterns are 
observed with clear cell-cell variations in tumor xenograft tissues, neuronal culture and mouse 
brain tissues. Hence, by offering the distinct advantage of optical resolution yet without the 
undesirable influence of fluorophores, our method will be a valuable tool to study energy demands 
of living systems with subcellular resolution.
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Glucose is the primary energy source for virtually all living organisms, from bacteria to 
human. As a hydrophilic small molecule, the uptake of glucose is mediated by cell surface 
transporters to pass through the otherwise impermeable hydrophobic plasma membrane, 
during which the ATP-independent facilitated diffusion down a glucose concentration 
gradient is the major pathway. Since the uptake of glucose is biologically regulated and 
closely correlated to a wide range of metabolic transformations, several prominent 
techniques have been developed to selectively image glucose uptake activity. Among them, 
radioactive tracers of glucose analogues (Figure 1a, b) are widely applied in clinical positron 
emission tomography (PET) to image glucose uptake activity in vivo. Although these PET 
analogues cannot be metabolized like D-glucose in the glycolytic pathway and thus 
accumulate inside cells, their net flux across cell membrane still reflects the total exogenous 
cellular glucose use when imaged at steady-state conditions.[1] Indeed, imaging steady-state 
glucose uptake level has been proved by extensive PET studies to be a key diagnostic 
marker in many diseases. More recently, magnetic resonance imaging (MRI) has achieved 
glucose imaging in tumors through chemical exchange saturation transfer and 
hyperpolarization of 13C labeled D-glucose.[2] Unfortunately, both PET and MRI techniques 
have limited spatial resolution, and cannot visualize glucose uptake in single cells. It is well 
appreciated that glucose uptake and energy demands in many crucial physiological (e.g., 
brain activity) and pathological (e.g., tumor development) processes are intrinsically 
heterogeneous at the cellular level.[3] Hence, to visualize glucose uptake activity in single 
living cells is indispensable in evaluating the metabolic demand of individual cells and 
unveiling the underlying cell-to-cell variations.
To monitor glucose uptake with cellular resolution, fluorophore-conjugated glucose 
analogues have been developed for fluorescence microscopy. 2-[N-(7-nitrobenz-2-oxa-1,3-
diazol-4-yl)amino]-2-deoxy-D-glucose (2-NBDG) (Figure 1c), which is also a glucose 
analogue that cannot be metabolized further in glycolysis, is one of the most popular probes 
and has been applied in a variety of cell types.[4] However, conjugation of glucose with 
fluorophores, which are mostly hydrophobic or charged, alters the hydrophilic property of 
natural glucose. Indeed, the water solubility of 2-NBDG is substantially reduced to ~10 
mg/ml. Moreover, physical sizes of fluorophores are always larger than glucose itself, due to 
the requirement of extended conjugation for visible light absorption. Thus, most fluorescent 
glucose analogues including 2-NBDG exhibit non-specific interactions and retentions in 
cells and tissues,[5] which would bias the true glucose distribution to varying degrees.
Here we report a new modality to visualize glucose uptake activity at the subcellular level 
by stimulated Raman scattering (SRS) imaging of vibrationally labeled D-glucose, and 
demonstrate its utility in live cancer cells, tumor xenograft tissues, primary neurons and 
mouse brain tissues. We designed, synthesized and characterized a novel glucose analogue, 
named 3-O-propargyl-D-glucose (3-OPG, 1, Figure 1d). 3-OPG has a minor chemical 
modification comparable to the PET tracer [11C]3-OMG (Figure 1b) yet avoiding the use of 
radioactive isotopes and allowing for subcellular optical imaging. Compared with 
fluorophores, alkyne tag (C≡C) is physically much smaller and has been proven to be 
chemically inert and bioorthogonal in cells by numerous click-chemistry studies.[6] Thus, we 
expect 3-OPG to not only preserve the hydrophilic nature of glucose but also prevent its 
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non-specific interactions in cells and tissues. Detection wise, alkyne tag exhibits a 
pronounced C ≡ C stretching Raman peak (~2100 cm−1) in the cell-silent spectral region.[7] 
Very recently alkyne tags have been coupled to SRS microscopy as a powerful vibrational 
label for metabolic imaging in live cells with high sensitivity, specificity and 
biocompatibility.[8] Therefore, by targeting the unique vibrational signature of alkyne tags, 
SRS imaging of 3-OPG uptake could be a valuable method to study energy demands and 
metabolic status in living systems with subcellular resolution and minimal perturbation.
We first synthesized 3-OPG by conjugating a propargyl group to glucose 3' OH group 
(Figure 1d). Briefly, commercially available 1,2:5,6-Di-O-isopropylidene-α-D-
glucofuranose 2 is reacted with propargyl bromide to selectively introduce the alkyne 
moiety onto the 3’ position, which gives 3 in 90% yield. Deprotection of 3 in strong acids 
affords 3-OPG 1 with 96% yield. Comparing 3-OPG with 3-OMG (Figure 1), one can 
readily tell their structures are highly similar except for the replacement of a methyl group 
by a propargyl group, which is a common strategy to introduce the alkyne group and 
maintain the original function, such as in propargyl-choline[6b] and O-propargyl-
puromycin.[6c]
Spontaneous Raman spectrum of 3-OPG is then characterized with a sharp and strong peak 
at 2129 cm−1 in the cell-silent region (Figure 2a, black), indicative of Raman-active mode of 
C ≡ C stretching. Negligible cellular background in 1800–2400 cm−1 is confirmed by both 
spontaneous Raman spectrum and SRS image at 2129 cm−1 of blank HeLa cells (Figure S1). 
Intrinsic Raman peaks of glucose, such as those from C-C and C-O bond vibrations, are also 
observed in the fingerprint region from 1000–1800 cm−1 (Figure 2a, black). Note that these 
peaks are not only much weaker than the alkyne peak but also overlapping with the cellular 
background (Figure 2a, red), which makes label-free Raman imaging of glucose in cells 
rather challenging.[9] Thus, introducing an exogenous alkyne tag not only promotes the 
sensitivity but also endows imaging specificity in the otherwise crowded cellular 
background without the need of spectral unmixing.
The uptake of 3-OPG is then tested in mammalian cell cultures. A distinct peak (2129 cm−1) 
emerges after incubating HeLa cells with 25 mM 3-OPG for 4 hours (Figure 2a, red), which 
exactly matches with that in the phosphate-buffered saline (PBS) solution spectrum of 3-
OPG, confirming cellular uptake of 3-OPG. No cytotoxicity of 3-OPG is observed from cell 
viability assays (Figure S2). Cellular distribution of 3-OPG can be visualized with high 
sensitivity and speed by SRS imaging of the alkyne Raman peak at 2129 cm−1 in HeLa cells 
incubated with 8 mM 3-OPG for 1 hour (Figure 2b). The corresponding off-resonance image 
at 2000 cm−1 confirms the background-free nature of SRS. As a reference, SRS image at 
1655 cm−1 shows cellular protein distribution by targeting at protein amide I band.
To quantify the intracellular uptake level, we correlated SRS intensity at 2129 cm−1 with 
known concentrations of 3-OPG solutions under identical conditions, which gives a 
detection sensitivity of 1.4 mM with 30 µs acquisition time per pixel and ~26 s/frame 
(Figure S3). For higher signal-to-noise ratio and more accurate quantifications, we chose 25 
mM 3-OPG as incubation concentration for further biochemistry characterizations.
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To validate that 3-OPG is transported into cells through glucose transporters, several control 
experiments are performed. First, uptake of 3-OPG is competed using D-glucose at different 
concentrations (Figure 3). As the concentration of D-glucose increases, cellular uptake of 3-
OPG decreases accordingly, reaching 78% with 10 mM D-glucose and 53% with 50 mM D-
glucose, consistent with the higher transporter affinity of D-glucose (Figure 3a–c). In 
contrast, with 50 mM L-glucose, which is not recognized by glucose transporters for its 
opposite chirality, 3-OPG uptake level is unaffected (Figure 3d).
Four different transporter inhibition and stimulation assays are then conducted. Using RNA 
interference to suppress the expression of GLUT1 transporter, HeLa cells transfected with 
10 nM GLUT1 siRNA for 48 hours show a much reduced uptake of 3-OPG (54%) compared 
to the control groups (Figure 3e, f). Moreover, HeLa cells incubated with 10 µM 
cytochalasin B, a potent inhibitor of glucose carriers, display a drastic reduction to 35% in 3-
OPG uptake (Figure 3g, h). Efflux experiments of 3-OPG loaded HeLa cells were also 
performed with a rapid decay after 30 minutes and the addition of cytochalasin B 
significantly inhibits the efflux of 3-OPG (Figure S4), indicating the transport of 3-OPG in 
both directions is carrier-mediated. We further studied the effect of insulin stimulation on 3-
OPG uptake by GLUT4 in rat muscle cells. With 1 µg/ml insulin for 24 hours, which 
stimulates GLUT4 translocation to plasma membrane, ~30% increase in 3-OPG uptake is 
observed in fused L6 cells (Figure S5), suggesting GLUT4-mediated uptake of 3-OPG. 
Taken together, these results further prove the glucose transporter dependence of 3-OPG 
uptake and its role as a D-glucose analogue to mammalian cells.
Uptake kinetics of 3-OPG is also examined (Figure S6 and S7). At 37 °C, buildup of 3-OPG 
inside HeLa cells reaches a plateau within 30 minutes, indicating fast uptake of 3-OPG at 
physiological temperature and allowing steady-state imaging. This equilibrium time is 
consistent with the reported size and weight dependence of transport kinetics for different 
glucose analogues.[10] Lowering to room temperature slows down 3-OPG uptake, as 
expected. Linear fitting of 3-OPG uptake at early times also reveals a ~3 folds decrease in 
initial transport rate from 37 °C to room temperature. Quantitatively, by plotting initial rates 
of 3-OPG uptake against different incubation concentrations (Figure S7), its Km and Vmax 
parameters are extracted in HeLa cells where GLUT1 is the most abundant isoform.[11] The 
fitted values of Km=26±4 mM and Vmax=0.71±0.05 mM/min of 3-OPG uptake turn out to 
be very close to that for 3-OMG uptake by human GLUT1 expressed in Xenopus oocytes 
(Km=13–20 mM and Vmax=0.74 mM/min assuming 106 oocytes/L).[12] Competition 
experiments using 3-OMG show a moderate reduction to 70% in 3-OPG uptake (Figure S8), 
which is again in agreement with their similar Km.
Further, important insights can be gained by simultaneously imaging cellular uptake of 3-
OPG and 2-NBDG by the same set of cells (Figure S9). While 2-NBDG displays a 
heterogeneous pattern with stronger signal enriched in cellular structures surrounding the 
nucleus, 3-OPG is distributed more homogeneously throughout the cells including inside the 
nucleus. Such differential contrast between 3-OPG and 2-NBDG is likely due to non-
specific retention of 2-NBDG in extra-nuclear organelles (such as endoplasmic reticulum) 
and its low permeability across nuclear membrane caused by the strong hydrophobicity 
and/or large size of the NBD fluorophores.[5] Hence we have obtained direct imaging 
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evidence that 3-OPG could be a more truthful probe to report the genuine glucose uptake 
and distribution inside cells.
Tumors are well known to have aberrant metabolism with upregulated glucose uptake. 
Cancer cells of different phenotypes also have varied glucose uptake levels, which could 
serve as a marker for tumor malignancy and metastatic potential.[2a] We thus compare 
glucose uptake activity between HeLa, a human cervical cancer cell line and U-87 MG, a 
human primary glioblastoma cell line, using 3-OPG as imaging probe (Figure S10). As the 
highest-grade glioma (WHO grade IV), glioblastoma is the most aggressive form of 
malignant primary brain tumor. Incubated with 3-OPG, U-87 MG cells display a much 
higher alkyne peak than that of HeLa cells in Raman spectra (Figure S10a), suggesting a 
more pronounced glucose uptake activity. SRS images further show the whole intracellular 
distribution of 3-OPG in both cancer cells. Consistent with the spectroscopic results, U-87 
MG cells indeed exhibit a brighter intracellular signal than HeLa cells, confirming much 
increased glucose uptake activity (Figure S10b). Quantitatively, 3-OPG uptake in U-87 MG 
cells is over 1.7 times higher than that of HeLa cells (Figure S10c). Thus SRS imaging of 3-
OPG uptake could be a useful technique to distinguish cancer cells with varied metabolic 
characteristics.
Uptake of 3-OPG is further visualized in mouse subcutaneous tumor xenograft model. 
Tumor regions with distinct glucose uptake levels are observed (Figure 4). In outer region of 
tumor, cells undergo fast proliferation and hence uptake glucose significantly (Figure 4a). In 
contrast, toward the center of tumor, cells display small and broken morphology (as shown 
in the amide channel at 1655 cm−1), suggesting necrosis and diminished cellular activity. 
Indeed, little 3-OPG uptake is seen in the SRS image with at least a 5 times lower signal 
than that in the tumor-propagating region (Figure 4b).
The interface between the two tumor regions can be clearly distinguished by highlighting the 
3-OPG uptake contrast at the single cell level, providing useful microscopic insights (Figure 
4c). Necrosis is known to be a histological hallmark of glioblastoma and an important 
predictor for tumor prognosis in clinical glioma diagnostics and staging.[13] We discover 
that the metabolic contrast from 3-OPG uptake is much more pronounced than the label-free 
images of endogenous lipid (at 2845 cm−1) or protein (at 1655 cm−1) distributions. Most 
notably, a small population of tumor cells with high glucose uptake activity is identified 
within the region of diminished activity (Figure 4c, arrowhead), reflecting cell-cell variation 
of metabolic status. Therefore, this showcases the capability of vibrational imaging of 
glucose uptake activity using 3-OPG and provides opportunity for studying intratumoral 
heterogeneity in energy consumptions during brain tumor growth with superb contrast and 
cellular resolution.
Brain is the central control of activity in higher organisms and has a high demand of energy. 
Fast and adequate glucose supply is critical for maintaining the neural activity. We therefore 
demonstrate imaging 3-OPG uptake in both in vitro neuron culture and ex vivo mouse brain 
tissue (Figure 5). In cultured mouse primary hippocampal neurons, not only high level of 3-
OPG is imaged inside the soma, but also it can be seen clearly in the neuronal processes 
(Figure 5a), reflecting energy need in axons and dendrites for neural signaling. 
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Intercellularly, significant variation in 3-OPG uptake is observed among different neurons, 
with over 2 times difference from cells with low-glucose level to high-glucose demanding 
cells (Figure 5a, arrowhead). This observation from the 3-OPG channel, which is absent 
from the corresponding protein amide image, indicates heterogeneous energy requirement at 
single neuron level. Going beyond the neuron cultures, 3-OPG uptake is also visualized in 
the hippocampus of mouse brain tissue slice cultured ex vivo. Pronounced signal is present 
in both the granule cell layer and nearby hilar region of dentate gyrus which is known to 
exhibit high metabolic activity[14] (Figure 5b). Thus, 3-OPG is generally applicable as a 
vibrational imaging probe for glucose transport in both tumor and brain study with 
subcellular resolution.
In summary, we have designed, synthesized and characterized a novel glucose analogue 
with an alkyne vibrational tag (3-OPG). By coupling SRS microscopy to the alkyne tag, we 
have demonstrated vibrational imaging of glucose uptake activity in living cells and tissues 
with high sensitivity, specificity and biocompatibility. Our method can differentiate cancer 
cells with varied metabolic activities and reveal heterogeneous glucose uptake patterns in 
tumor xenograft tissues as well as in neuronal culture and mouse brain tissues at cellular 
resolution. Previous studies have been reported on glucose sensing in blood and metabolic 
incorporation using isotope-labeled glucose for imaging downstream products with Raman 
techniques.[15] However, they are either not in cellular environment or cannot visualize 
glucose uptake activity specifically. If compared to the classic PET tracers, 3-OPG can be 
synthesized in a highly cost-effective way without special handling of radioactive materials 
and endows optical imaging with subcellular resolution. If compared to the bulky 
fluorescent glucose analogues, 3-OPG has a minor structural modification without adding a 
significant size and weight to glucose, rendering better affinity to glucose transporters, less 
non-specific interaction and higher translocation efficiency (e.g., crossing the blood-brain 
barrier). With the use of near-infrared lasers for nonlinear excitation, SRS is capable of 
high-resolution and deep tissue imaging with minimal phototoxicity and essentially no 
photobleaching,[16] and has recently achieved video-rate imaging in live animals and 
humans with potential clinical applications.[17] We therefore expect that vibrational imaging 
of 3-OPG with SRS microscopy would become an attractive technique for studying glucose 
uptake activity at the cellular level, especially in brain and malignant tumors that are 
inherently in high demand of energy.
Supplementary Material
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Figure 1. 
Structures of existing D-glucose analogues and synthesis of the new 3-O-propargyl-D-
glucose. (a) [18F]2-Fluoro-2-deoxy-D-glucose ([18F]FDG). (b) [11C]3-O-methyl-D-glucose 
([11C]3-OMG). (c) 2-NBD-2-deoxy-D-glucose (2-NBDG). (d) Synthetic route of 3-OPG 1. 
a) NaH, propargyl bromide, DMF, RT, 12 h, 90%; b) Dowex® 50WX8, H2O, 80°C, 20 h, 
96%.
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Figure 2. 
Uptake of 3-OPG in live mammalian cells. (a) Spontaneous Raman spectra of 25 mM 3-
OPG solution in PBS (black) and HeLa cells incubated with 25 mM 3-OPG for 4 hours 
(red). (b) SRS imaging of 3-OPG uptake (2129 cm−1) in live HeLa cells incubated with 8 
mM 3-OPG for 1 hour. The average intracellular concentration is estimated to be 3–5 mM. 
Images at 2000 cm−1 (off-resonance) and 1655 cm−1 (protein amide I) show the same area 
of cells. The 2129 cm−1 color bars in all images correspond to a linear 3-OPG concentration 
range of 0–26 mM, unless otherwise noted. Scale bar: 20 µm.
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Figure 3. 
Glucose transporter dependence of 3-OPG uptake in mammalian cells. Representative SRS 
images of live HeLa cells incubated with 3-OPG in the presence of (a) 0 mM D-glucose, (b) 
10 mM D-glucose, (c) 50 mM D-glucose, and (d) 50 mM L-glucose. (e, f) HeLa cells were 
transfected with 10 nM negative control siRNA (e) or GLUT1 siRNA (f) before incubation 
with 3-OPG. (g, h) HeLa cells were incubated with 3-OPG in the presence of DMSO vehicle 
(g) or 10 µM cytochalasin B (h). Scale bar: 20 µm. (i) Relative SRS intensity of 3-OPG 
uptake in HeLa cells under the conditions above. Data are shown as Mean + standard 
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deviation (SD) (n≥3 replicates for each group). *, p<0.05; ***, p<0.001 by Student’s t-test. 
p<0.05 is considered statistically significant.
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Figure 4. 
SRS imaging of 3-OPG uptake in U-87 MG tumor xenograft tissues. (a) Strong uptake of 3-
OPG in the proliferating region of tumor. (b) Little uptake is seen in the tumor region with 
necrotic cell morphology. The 2129 cm−1 color bars in (a, b) correspond to a 3-OPG 
concentration range of 0–53 mM. (c) Sharp contrast of 3-OPG uptake at the interface of two 
tumor regions. Scale bar: 40 µm.
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Figure 5. 
SRS imaging of 3-OPG uptake in neuronal systems. (a) SRS images of cultured mouse 
primary hippocampal neurons incubated with 3-OPG. Scale bar: 20 µm. (b) SRS images of 
mouse brain tissue slice cultured ex vivo with 3-OPG. Significant uptake of 3-OPG is seen at 
the granule cell layer of dentate gyrus. Scale bar: 40 µm.
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